Skip to main content

Cullinan Holdco Scsp

Cullinan Holdco SCSp is the Luxembourg-based financial holding and debt-issuing vehicle for the Neopharmed Gentili Group, a prominent Italian pharmaceutical company specializing in the research, development, and commercialization of branded prescription drugs, generic medicines, and therapeutic solutions for cardiovascular, respiratory, and metabolic diseases. The company issues corporate debt instruments in international capital markets to fund the strategic investments, research pipelines, and refinancing requirements of the Neopharmed Gentili Group. Neopharmed Gentili is an established provider of high-quality therapeutic medicines to the Italian healthcare system and international pharmaceutical markets. Cash flows servicing Cullinan Holdco's debt obligations are derived directly from intercompany loan repayments backed by the operating cash flows of the Neopharmed Gentili pharmaceutical manufacturing and marketing business. The company is headquartered in Luxembourg, with primary operational management based in Milan, Italy.

4 of the funds FundTelligence covers report a position in Cullinan Holdco Scsp.

Sector
Financials
Country
Luxembourg
Funds holding it
4

Funds holding Cullinan Holdco Scsp

Loading...